Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
Pediatrics|November 5, 2002
Reported adverse drug events in infants and children under 2 years of ageThomas J Moore, Sheila R Weiss, Sigal Kaplan, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 19, 2020
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis RegistrySigal Kaplan, Andrew Lee, Noreen Caine, et al.Accident; Analysis and Prevention|March 10, 2015
Parents' and peers' contribution to risky driving of male teen driversOrit Taubman-Ben-Ari, Sigal Kaplan, Tsippy Lotan, et al.Traffic Injury Prevention|January 21, 2016
Understanding traffic crash under-reporting: Linking police and medical records to individual and crash characteristicsKira H Janstrup, Sigal Kaplan, Tove Hels, et al.Current Medical Research and Opinion|December 21, 2021
Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UKBirgit Ehlken, Chihiro Nishikawa, Sigal Kaplan, et al.Current Medical Research and Opinion|January 18, 2021
Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database studySigal Kaplan, Massoud Toussi, Alison Evans, et al.Journal of Drug Assessment|May 21, 2019
Prescribing patterns from medical chart abstraction of patients administered lipegfilgrastim: a pilot study in EuropeSigal Kaplan, Nicole Lang, Maja Gasparic, et al.Pharmacoepidemiology and Drug Safety|October 27, 2020
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in EuropeMassoud Toussi, Margarita Shlaen, Florence Coste, et al.Frontiers in Endocrinology|April 5, 2021
Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort StudySigal Kaplan, Rachel Levy-Toledano, Miranda Davies, et al.Pharmacoepidemiology and Drug Safety|November 20, 2020
Effectiveness of risk minimisation measures for valproate: A cross-sectional survey among physicians in EuropeMassoud Toussi, Bardoulat Isabelle, Stephanie Tcherny-Lessenot, et al.Pageof 7